In Silico Protein Design Market Report 2026

The in silico protein design market size has grown exponentially in recent years. It will grow from $1.87 billion in 2025 to $2.27 billion in 2026 at a compound annual growth rate (CAGR) of 21.2%. The growth in the historic period can be attributed to advancements in computational biology tools, growing availability of protein structure databases, increased use of in silico methods in drug discovery, expansion of academic bioinformatics research, rising demand for cost-efficient protein design approaches.

The in silico protein design market size is expected to see exponential growth in the next few years. It will grow to $4.86 billion in 2030 at a compound annual growth rate (CAGR) of 20.9%. The growth in the forecast period can be attributed to increasing investments in ai-based drug discovery, rising adoption of personalized medicine development, expansion of cloud computing infrastructure, growing use of automation in biological research, increasing collaboration between biotech and software companies. Major trends in the forecast period include increasing adoption of ai-driven protein modelling platforms, rising use of cloud-based simulation software, growing integration of machine learning in structure prediction, expansion of computational enzyme engineering, enhanced focus on rapid protein optimization.

The rising need for personalized medicine is anticipated to boost the in silico protein design market in the years ahead. Personalized medicine involves customizing medical treatments and prevention approaches to match an individual's distinct genetic profile, lifestyle, and surroundings. Demand for personalized medicine is surging thanks to progress in genomic technologies, while the expanding use of value-based care models stems from efforts to enhance patient results and cut total healthcare expenses. In silico protein design meets this demand by facilitating the quick creation of bespoke therapeutic proteins suited to specific patient characteristics. For instance, in February 2024, the Personalized Medicine Coalition (PMC), a US-based non-profit, reported that the FDA approved 16 new personalized therapies for rare disease patients in 2023, up from only six in 2022. Thus, the growing demand for personalized medicine is fueling expansion in the in silico protein design market.

Major companies in the in silico protein design market are prioritizing advanced solutions, like push-button protein design platforms, to speed up drug discovery, enhance therapeutic effectiveness, and facilitate novel biologics development. Push-button protein design platforms are user-friendly tools that enable scientists to generate and edit proteins rapidly through automated processes, minimizing the need for manual effort. For example, in July 2025, UK-based biotech firm Latent Labs launched Latent-X, a generative AI model available via a web-based push-button interface. This allows non-coders to input targets and design macrocycles and mini-binders at the atomic scale. The platform achieves 91-100% hit rates for macrocycles and 10-64% for mini-binders, delivers picomolar to micromolar binding affinities with lab-confirmed specificity, and generates full sequences and structures over ten times faster than prior approaches. Such advancements are broadening access and driving faster innovation in protein therapeutics.

In July 2023, BioNTech SE, a Germany-based biotechnology firm, purchased InstaDeep Ltd. for an undisclosed sum. Through this acquisition, BioNTech and InstaDeep sought to merge BioNTech’s strengths in immunotherapy and vaccine development with InstaDeep’s advanced artificial intelligence and machine learning capabilities. This combination aims to speed up and improve AI-driven drug discovery, design, and development, ultimately advancing the creation of novel therapies for cancer and infectious diseases. InstaDeep Ltd., a UK-based firm, specializes in in silico protein design technologies.

Major companies operating in the in silico protein design market are Dassault Systèmes SE, Schrödinger Inc., Generate Biomedicines Inc., Insilico Medicine Inc., Chemical Computing Group ULC, Arzeda Corp., Outpace Bio Inc., Evozyne Inc., Cradle Bio B.V., Seismic Therapeutics Inc., Profluent Bio Inc., Nabla Bio Inc., Antiverse Ltd., EvolutionaryScale Inc., RevolKa Ltd., Molecular Discovery Ltd., Inte:Ligand GmbH, Kuano Ltd., AI Proteins Inc., Menten AI Inc.

North America was the largest region in the in silico protein design market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the in silico protein design market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the in silico protein design market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are impacting the in silico protein design market by increasing costs associated with imported high-performance computing hardware, specialized servers, and advanced data storage infrastructure required for large-scale molecular simulations. North America and Europe are most affected due to dependence on imported computing components, while Asia-Pacific faces higher costs in cloud infrastructure expansion. These tariffs are raising operational expenses for research organizations and software providers. However, they are also encouraging regional data center development, domestic hardware manufacturing, and optimization of cloud-based protein design platforms.

The in silico protein design market research report is one of a series of new reports that provides in silico protein design market statistics, including in silico protein design industry global market size, regional shares, competitors with a in silico protein design market share, detailed in silico protein design market segments, market trends and opportunities, and any further data you may need to thrive in the in silico protein design industry. This in silico protein design market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

In silico protein design involves crafting or altering protein structures through computer modeling and simulations, bypassing the need for lab experiments. Computational tools predict amino acid sequence folding and interactions, allowing the creation of proteins with specific shapes and functions. This method accelerates discovery, cuts expenses, and lets researchers test vast options virtually before physical validation.

The primary software categories for in silico protein design consist of cloud-based platforms and on-premise solutions. Cloud-based platforms are online tools and services that run via the internet, enabling users to utilize sophisticated protein design features without local installation or upkeep. They incorporate technologies like molecular modeling, AI and machine learning methods, homology modeling, and more, supporting applications in drug discovery and development, enzyme engineering, biomarker identification, vaccinology, and academic studies. These tools serve various users, such as pharmaceutical and biotech firms, academic and research organizations, and additional sectors.

The in silico protein design market consists of revenues earned by entities by providing services such as protein structure modelling, protein engineering and optimization, antibody and biologic design, molecular docking, and virtual screening. The market value includes the value of related goods sold by the service provider or included within the service offering. The in silico protein design market also includes sales of optimized proteins, enzyme variants, peptides and vaccine candidates, protein models, and research kits. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.